These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3123693)

  • 1. Fetal valproate syndrome: is there a recognisable phenotype?
    Winter RM; Donnai D; Burn J; Tucker SM
    J Med Genet; 1987 Nov; 24(11):692-5. PubMed ID: 3123693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fetal valproate syndrome.
    DiLiberti JH; Farndon PA; Dennis NR; Curry CJ
    Am J Med Genet; 1984 Nov; 19(3):473-81. PubMed ID: 6439041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal Valproate Syndrome - Still a Problem Today!
    Wiedemann K; Stüber T; Rehn M; Frieauff E
    Z Geburtshilfe Neonatol; 2017 Oct; 221(5):243-246. PubMed ID: 29073690
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal valproate syndrome: the Irish experience.
    Mohd Yunos H; Green A
    Ir J Med Sci; 2018 Nov; 187(4):965-968. PubMed ID: 29396778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate fetopathy.
    Sargar KM; Herman TE; Siegel MJ
    J Perinatol; 2015 Jan; 35(1):82-3. PubMed ID: 25549012
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.
    Kozma C
    Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility.
    Malm H; Kajantie E; Kivirikko S; Kääriäinen H; Peippo M; Somer M
    Neurology; 2002 Aug; 59(4):630-3. PubMed ID: 12196666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septo-optic dysplasia as a manifestation of valproic acid embryopathy.
    McMahon CL; Braddock SR
    Teratology; 2001 Aug; 64(2):83-6. PubMed ID: 11460259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metopic craniosynostosis, probable effect of intrauterine exposure to maternal valproate treatment].
    Chabrolle JP; Bensouda B; Bruel H; Simon A; Poinsot J; Ickowicz V; Degre S
    Arch Pediatr; 2001 Dec; 8(12):1333-6. PubMed ID: 11811028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal valproate syndrome with reduction deformity of limb.
    Okada T; Tomoda T; Hisakawa H; Kurashige T
    Acta Paediatr Jpn; 1995 Feb; 37(1):58-60. PubMed ID: 7754767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gollop-Wolfgang Complex in a baby born to an epileptic mother treated with valproic acid during pregnancy].
    Mercadal Orfila G; Blasco Mascaró I
    Farm Hosp; 2010; 34(3):149-51. PubMed ID: 20471572
    [No Abstract]   [Full Text] [Related]  

  • 12. The longer term outcome of children born to mothers with epilepsy.
    Adab N; Kini U; Vinten J; Ayres J; Baker G; Clayton-Smith J; Coyle H; Fryer A; Gorry J; Gregg J; Mawer G; Nicolaides P; Pickering L; Tunnicliffe L; Chadwick DW
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1575-83. PubMed ID: 15491979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital malformations associated with maternal use of valproic acid.
    Huot C; Gauthier M; Lebel M; Larbrisseau A
    Can J Neurol Sci; 1987 Aug; 14(3):290-3. PubMed ID: 3117346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preaxial polydactyly in the fetal valproate syndrome.
    Buntinx IM
    Eur J Pediatr; 1992 Dec; 151(12):919-20. PubMed ID: 1473550
    [No Abstract]   [Full Text] [Related]  

  • 15. [Facial dysmorphism related to valproic acid ingestion during pregnancy].
    Chevallier B; Hertz L; Lagardere B; Gallet JP
    Arch Fr Pediatr; 1986; 43(7):489-90. PubMed ID: 3099722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital abnormalities in two sibs exposed to valproic acid in utero.
    Chitayat D; Farrell K; Anderson L; Hall JG
    Am J Med Genet; 1988 Oct; 31(2):369-73. PubMed ID: 3148279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Embryofetopathy due to valproate: a pathology only little known. Apropos of 4 cases].
    Espinasse M; Manouvrier S; Boute O; Farriaux JP
    Arch Pediatr; 1996 Sep; 3(9):896-9. PubMed ID: 8949354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of the fetal valproate syndrome phenotype.
    Ardinger HH; Atkin JF; Blackston RD; Elsas LJ; Clarren SK; Livingstone S; Flannery DB; Pellock JM; Harrod MJ; Lammer EJ
    Am J Med Genet; 1988 Jan; 29(1):171-85. PubMed ID: 3125743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
    Thisted E; Ebbesen F
    Arch Dis Child; 1993 Sep; 69(3 Spec No):288-91. PubMed ID: 8215567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.